Haverford Trust Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Sell
47,600
-1,446
-3% -$129K 0.04% 131
2025
Q4
$3.88M Sell
49,046
-973
-2% -$76.3K 0.03% 134
2025
Q3
$4M Sell
50,019
-2,679
-5% -$229K 0.04% 133
2025
Q2
$4.79M Buy
52,698
+1,178
+2% +$108K 0.05% 124
2025
Q1
$4.83M Sell
51,520
-1,242
-2% -$111K 0.05% 122
2024
Q4
$4.8M Sell
52,762
-314
-0.6% -$30K 0.05% 121
2024
Q3
$5.51M Buy
53,076
+28
+0.1% +$2.85K 0.05% 115
2024
Q2
$5.15M Sell
53,048
-379
-0.7% -$35K 0.05% 115
2024
Q1
$4.81M Sell
53,427
-1,286
-2% -$109K 0.05% 120
2023
Q4
$4.36M Buy
54,713
+1,850
+3% +$139K 0.05% 114
2023
Q3
$3.76M Sell
52,863
-2,560
-5% -$191K 0.05% 119
2023
Q2
$4.27M Sell
55,423
-1,655
-3% -$128K 0.05% 111
2023
Q1
$4.29M Buy
57,078
+255
+0.4% +$19K 0.05% 114
2022
Q4
$4.48M Sell
56,823
-300
-0.5% -$22.5K 0.06% 107
2022
Q3
$4.01M Sell
57,123
-204
-0.4% -$16K 0.06% 111
2022
Q2
$4.59M Buy
57,327
+200
+0.4% +$15.6K 0.06% 107
2022
Q1
$4.33M Buy
57,127
+1,438
+3% +$114K 0.05% 116
2021
Q4
$4.75M Sell
55,689
-496
-0.9% -$38.7K 0.05% 114
2021
Q3
$4.25M Buy
56,185
+3,797
+7% +$302K 0.05% 118
2021
Q2
$4.26M Buy
52,388
+1,064
+2% +$87K 0.05% 120
2021
Q1
$4.05M Buy
51,324
+5,208
+11% +$408K 0.05% 109
2020
Q4
$3.94M Sell
46,116
-311
-0.7% -$25.7K 0.06% 96
2020
Q3
$3.58M Sell
46,427
-3,169
-6% -$242K 0.06% 99
2020
Q2
$3.63M Sell
49,596
-220
-0.4% -$15.6K 0.06% 97
2020
Q1
$3.31M Buy
49,816
+4,950
+11% +$349K 0.07% 93
2019
Q4
$3.09M Sell
44,866
-2,774
-6% -$189K 0.05% 105
2019
Q3
$3.5M Buy
47,640
+1,401
+3% +$102K 0.06% 95
2019
Q2
$3.31M Sell
46,239
-1,306
-3% -$92.7K 0.06% 95
2019
Q1
$3.26M Sell
47,545
-927
-2% -$59.9K 0.06% 95
2018
Q4
$2.88M Sell
48,472
-3,541
-7% -$222K 0.06% 94
2018
Q3
$3.48M Sell
52,013
-1,376
-3% -$91.7K 0.06% 96
2018
Q2
$3.46M Sell
53,389
-3,242
-6% -$212K 0.07% 95
2018
Q1
$4.06M Buy
56,631
+330
+0.6% +$23.7K 0.08% 86
2017
Q4
$4.25M Buy
56,301
+1,946
+4% +$142K 0.08% 86
2017
Q3
$3.96M Sell
54,355
-95
-0.2% -$6.85K 0.08% 81
2017
Q2
$4.04M Sell
54,450
-4,407
-7% -$327K 0.09% 80
2017
Q1
$4.31M Buy
58,857
+841
+1% +$58.9K 0.1% 75
2016
Q4
$3.8M Sell
58,016
-2,835
-5% -$194K 0.09% 79
2016
Q3
$4.51M Buy
60,851
+1,542
+3% +$114K 0.11% 75
2016
Q2
$4.34M Sell
59,309
-2,149
-3% -$153K 0.11% 77
2016
Q1
$4.34M Sell
61,458
-1,843
-3% -$123K 0.11% 77
2015
Q4
$4.22M Buy
63,301
+1,089
+2% +$72.4K 0.11% 78
2015
Q3
$3.95M Sell
62,212
-666
-1% -$43.5K 0.11% 72
2015
Q2
$4.11M Sell
62,878
-347
-0.5% -$23.5K 0.11% 75
2015
Q1
$4.38M Sell
63,225
-1,320
-2% -$91.2K 0.12% 77
2014
Q4
$4.47M Buy
64,545
+153
+0.2% +$10.3K 0.13% 78
2014
Q3
$4.2M Buy
64,392
+2,698
+4% +$178K 0.13% 75
2014
Q2
$4.21M Sell
61,694
-475
-0.8% -$31.8K 0.12% 74
2014
Q1
$4.03M Sell
62,169
-32,111
-34% -$2.02M 0.12% 73
2013
Q4
$6.15M Sell
94,280
-1,090
-1% -$69.8K 0.17% 75
2013
Q3
$5.66M Sell
95,370
-409
-0.4% -$24.2K 0.21% 60
2013
Q2
$5.49M Buy
+95,779
New +$5.69M 0.18% 73

Other funds holding CL

Haverford Trust Company's CL Position: Q1 2026 in Review

Haverford Trust Company reduced its Colgate-Palmolive (CL) stake by 2.9% in Q1 2026, selling an estimated $129K and leaving 47,600 shares worth $4.06M. The position accounts for 0.04% of the portfolio, ranked #131.

Haverford Trust Company first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.15M in Q4 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Haverford Trust Company held 47,600 shares of Colgate-Palmolive worth $4.06M as of Q1 2026.
  • Haverford Trust Company sold 1,446 Colgate-Palmolive shares in Q1 2026, an estimated $129K.
  • Colgate-Palmolive made up 0.04% of Haverford Trust Company's portfolio in Q1 2026, its #131 holding.
  • Haverford Trust Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Haverford Trust Company's Colgate-Palmolive position peaked at $6.15M in Q4 2013.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Haverford Trust Company's 13F filing for Q1 2026, filed 11 May 2026.